rs35483263

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_001282116.2(RFX3):​c.1683G>A​(p.Gln561Gln) variant causes a synonymous change. The variant allele was found at a frequency of 0.00714 in 1,613,992 control chromosomes in the GnomAD database, including 70 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0046 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0074 ( 69 hom. )

Consequence

RFX3
NM_001282116.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.17
Variant links:
Genes affected
RFX3 (HGNC:9984): (regulatory factor X3) This gene is a member of the regulatory factor X gene family, which encodes transcription factors that contain a highly-conserved winged helix DNA binding domain. The protein encoded by this gene is structurally related to regulatory factors X1, X2, X4, and X5. It is a transcriptional activator that can bind DNA as a monomer or as a heterodimer with other RFX family members. Multiple transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 9-3257122-C-T is Benign according to our data. Variant chr9-3257122-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 778377.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00461 (701/152160) while in subpopulation NFE AF= 0.00791 (538/68012). AF 95% confidence interval is 0.00736. There are 1 homozygotes in gnomad4. There are 288 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 701 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RFX3NM_001282116.2 linkc.1683G>A p.Gln561Gln synonymous_variant Exon 14 of 17 ENST00000617270.5 NP_001269045.1 P48380-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RFX3ENST00000617270.5 linkc.1683G>A p.Gln561Gln synonymous_variant Exon 14 of 17 2 NM_001282116.2 ENSP00000482598.1 P48380-1

Frequencies

GnomAD3 genomes
AF:
0.00461
AC:
701
AN:
152042
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00133
Gnomad AMI
AF:
0.00549
Gnomad AMR
AF:
0.00406
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00791
Gnomad OTH
AF:
0.00717
GnomAD3 exomes
AF:
0.00466
AC:
1169
AN:
251016
Hom.:
7
AF XY:
0.00461
AC XY:
625
AN XY:
135650
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00454
Gnomad ASJ exome
AF:
0.00586
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00124
Gnomad FIN exome
AF:
0.000785
Gnomad NFE exome
AF:
0.00741
Gnomad OTH exome
AF:
0.00539
GnomAD4 exome
AF:
0.00741
AC:
10827
AN:
1461832
Hom.:
69
Cov.:
31
AF XY:
0.00728
AC XY:
5297
AN XY:
727218
show subpopulations
Gnomad4 AFR exome
AF:
0.00137
Gnomad4 AMR exome
AF:
0.00523
Gnomad4 ASJ exome
AF:
0.00536
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00134
Gnomad4 FIN exome
AF:
0.00120
Gnomad4 NFE exome
AF:
0.00885
Gnomad4 OTH exome
AF:
0.00628
GnomAD4 genome
AF:
0.00461
AC:
701
AN:
152160
Hom.:
1
Cov.:
31
AF XY:
0.00387
AC XY:
288
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.00133
Gnomad4 AMR
AF:
0.00406
Gnomad4 ASJ
AF:
0.00461
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.000471
Gnomad4 NFE
AF:
0.00791
Gnomad4 OTH
AF:
0.00710
Alfa
AF:
0.00643
Hom.:
4
Bravo
AF:
0.00499
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00823
EpiControl
AF:
0.00723

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

RFX3: BP4, BS2 -

RFX3-related disorder Benign:1
May 13, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
9.5
DANN
Benign
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35483263; hg19: chr9-3257122; API